Acute Liver Failure in Children

  • Naresh Shanmugam
  • Anil DhawanEmail author


“Acute liver failure” (ALF) and “fulminant liver failure” are terms used interchangeably to describe severe and sudden onset of liver cell dysfunction leading on to synthetic and detoxification failure across all age groups. Considerable variations exist between ALF in children and adults, in terms of aetiology and prognosis. Encephalopathy is not essential to make a diagnosis of ALF in children but when present has a bad prognosis. Early recognition of ALF and initiation of supportive management improve the outcome. Liver transplantation remains the only definitive treatment when supportive medical management fails.


Acute liver failure Liver transplantation Hepatocyte transplantation Neonatal haemochromatosis Transplant listing 


  1. 1.
    Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMedGoogle Scholar
  2. 2.
    Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis. 1996;16(4):349–55.CrossRefGoogle Scholar
  3. 3.
    Squires RH Jr, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8.CrossRefGoogle Scholar
  4. 4.
    Alam S, et al. Profile and outcome of first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int. 2017;37(10):1508–14.CrossRefGoogle Scholar
  5. 5.
    Shanmugam NP, et al. Neonatal liver failure: aetiologies and management—state of the art. Eur J Pediatr. 2011;170(5):573–81.CrossRefGoogle Scholar
  6. 6.
    Bower WA, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007;102(11):2459–63.CrossRefGoogle Scholar
  7. 7.
    Larrey D. [Hepatotoxicity of drugs and chemicals]. Gastroenterol Clin Biol. 2009;33(12):1136–46.Google Scholar
  8. 8.
    Davis M. Protective agents for acetaminophen overdose. Semin Liver Dis. 1986;6(2):138–47.CrossRefGoogle Scholar
  9. 9.
    Bjornsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther. 2010;32(1):3–13.CrossRefGoogle Scholar
  10. 10.
    Idilman R, et al. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience. J Clin Gastroenterol. 2010;44(6):e128–32.CrossRefGoogle Scholar
  11. 11.
    Ghabril M, Chalasani N, Bjornsson E. Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol. 2010;26(3):222–6.CrossRefGoogle Scholar
  12. 12.
    Andrade RJ, et al. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol. 2007;13(3):329–40.CrossRefGoogle Scholar
  13. 13.
    Ciocca M, et al. Prognostic factors in paediatric acute liver failure. Arch Dis Child. 2008;93(1):48–51.CrossRefGoogle Scholar
  14. 14.
    Krawczynski K, Kamili S, Aggarwal R. Global epidemiology and medical aspects of hepatitis E. Forum (Genova). 2001;11(2):166–79.Google Scholar
  15. 15.
    Bhatia V, et al. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology. 2008;48(5):1577–85.CrossRefGoogle Scholar
  16. 16.
    Samanta J, Sharma V. Dengue and its effects on liver. World J Clin Cases. 2015;3(2):125–31.CrossRefGoogle Scholar
  17. 17.
    Hardy L, et al. Neonatal hemochromatosis. Genetic analysis of transferrin-receptor, H-apoferritin, and L-apoferritin loci and of the human leukocyte antigen class I region. Am J Pathol. 1990;137(1):149–53.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Whitington PF, Malladi P. Neonatal hemochromatosis: is it an alloimmune disease? J Pediatr Gastroenterol Nutr. 2005;40(5):544–9.CrossRefGoogle Scholar
  19. 19.
    Pan X, et al. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology. 2010;51(6):2061–8.CrossRefGoogle Scholar
  20. 20.
    Smith SR, et al. Minor salivary gland biopsy in neonatal hemochromatosis. Arch Otolaryngol Head Neck Surg. 2004;130(6):760–3.CrossRefGoogle Scholar
  21. 21.
    Treem WR, Sokol RJ. Disorders of the mitochondria. Semin Liver Dis. 1998;18(3):237–53.CrossRefGoogle Scholar
  22. 22.
    Dhawan A, Mieli-Vergani G. Liver transplantation for mitochondrial respiratory chain disorders: to be or not to be? Transplantation. 2001;71(5):596–8.CrossRefGoogle Scholar
  23. 23.
    Sasaki K, et al. Liver transplantation for mitochondrial respiratory chain disorder: a single-center experience and excellent marker of differential diagnosis. Transplant Proc. 2017;49(5):1097–102.CrossRefGoogle Scholar
  24. 24.
    Dhawan A, et al. Wilson’s disease in children: 37-year experience and revised King’s score for liver transplantation. Liver Transpl. 2005;11(4):441–8.CrossRefGoogle Scholar
  25. 25.
    Henter JI, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRefGoogle Scholar
  26. 26.
    Kader A, et al. Leukaemia presenting with fulminant hepatic failure in a child. Eur J Pediatr. 2004;163(10):628–9.PubMedGoogle Scholar
  27. 27.
    Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease. World J Gastroenterol. 2008;14(21):3360–7.CrossRefGoogle Scholar
  28. 28.
    Narkewicz MR, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr. 2009;155(6):801–6.e1.CrossRefGoogle Scholar
  29. 29.
    Ostapowicz G, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–54.CrossRefGoogle Scholar
  30. 30.
    O’Grady JG, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–45.CrossRefGoogle Scholar
  31. 31.
    Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41(5):1179–97.CrossRefGoogle Scholar
  32. 32.
    Koch A, Trautwein C. N-acetylcysteine on its way to a broader application in patients with acute liver failure. Hepatology. 2010;51(1):338–40.CrossRefGoogle Scholar
  33. 33.
    Squires RH, et al. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology. 2013;57(4):1542–9.CrossRefGoogle Scholar
  34. 34.
    Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care. 2007;23(2):129–35.CrossRefGoogle Scholar
  35. 35.
    Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet. 2004;364(9446):1690–8.CrossRefGoogle Scholar
  36. 36.
    Dhawan A. Clinical human hepatocyte transplantation: current status and challenges. Liver Transpl. 2015;21(Suppl 1):S39–44.CrossRefGoogle Scholar
  37. 37.
    Faraj W, et al. Auxiliary liver transplantation for acute liver failure in children. Ann Surg. 2010;251(2):351–6.CrossRefGoogle Scholar
  38. 38.
    Strom SC, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 1997;63(4):559–69.CrossRefGoogle Scholar
  39. 39.
    Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol. 2015;62(1 Suppl):S157–69.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institute of Advanced Paediatrics, Dr. Rela Institute and Medical CentreChennaiIndia
  2. 2.Paediatric Liver GI and Nutrition Center and Mowat LabsKing’s College HospitalLondonUK

Personalised recommendations